fludeoxyglucose f 18 (24562-001)

Drug Facts

Product Profile

Brand Name fludeoxyglucose f 18

Generic Name fludeoxyglucose f-18

Labeler biomedical research foundation of northwest louisiana

Dosage Form INJECTION, SOLUTION

Routes

INTRAVENOUS

Active Ingredients

fludeoxyglucose f-18 300 mCi/mL

Manufacturer

Biomedical Research Foundation of Northwest Louisiana

Identifiers & Regulatory

Product NDC 24562-001

Product ID 24562-001_4d02df76-e1f1-4ae6-be11-dc75d2b37c65

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA203710

Listing Expiration 2026-12-31

Marketing Start 2015-05-14

Pharmacologic Class

Established (EPC)

radioactive diagnostic agent [epc]

Mechanism of Action

radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24562001

Hyphenated Format 24562-001

Supplemental Identifiers

UNII

0Z5B2CJX4D

NUI

N0000177914 N0000000205

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f 18 (source: ndc)

Generic Name fludeoxyglucose f-18 (source: ndc)

Application Number ANDA203710 (source: ndc)

Routes

INTRAVENOUS

source: ndc

Resolved Composition

Strengths

300 mCi/mL

source: ndc

Packaging

30 mL in 1 VIAL, GLASS (24562-001-30)

source: ndc

Packages (1)

24562-001-30 30 mL in 1 VIAL, GLASS (24562-001-30)

Ingredients (1)

fludeoxyglucose f-18 (300 mCi/mL)

Linked Drug Pages (1)

Fludeoxyglucose F 18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRAVENOUS"], "spl_id": "4d02df76-e1f1-4ae6-be11-dc75d2b37c65", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["1deaaa92-1c98-4295-8aa6-7a70bc29f55d"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["Biomedical Research Foundation of Northwest Louisiana"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, GLASS (24562-001-30)", "package_ndc": "24562-001-30", "marketing_start_date": "20150514"}], "brand_name": "Fludeoxyglucose F 18", "product_id": "24562-001_4d02df76-e1f1-4ae6-be11-dc75d2b37c65", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "24562-001", "generic_name": "Fludeoxyglucose F-18", "labeler_name": "Biomedical Research Foundation of Northwest Louisiana", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose", "brand_name_suffix": "F 18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203710", "marketing_category": "ANDA", "marketing_start_date": "20150514", "listing_expiration_date": "20261231"}